doi: 10.1007/BF01106708.
A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics
- PMID: 3783448
- DOI: 10.1007/BF01106708
Item in Clipboard
A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics
J Pharmacokinet Biopharm.
1986 Jun.
Abstract
A dispersion model of hepatic elimination is presented to describe metabolite formation and elimination kinetics within the liver, consistent with the known physiology and biochemistry of this organ. The model is based on the spread in residence times of blood flowing through the liver. This dispersion model is shown to be more consistent with transient and steady-state data obtained after the single passage of phenacetin and acetaminophen through the liver (both normal and retrograde perfusions) than other models of hepatic elimination. The dispersion model is suitable for the evaluation of enzyme heterogeneity using experimentally obtained metabolite data.
Similar articles
-
The effect of intercellular distribution of drug-metabolizing enzymes on the kinetics of stable metabolite formation and elimination by liver: first-pass effects.Drug Metab Rev. 1983;14(1):61-76. doi: 10.3109/03602538308991381. Drug Metab Rev. 1983. PMID: 6839942 No abstract available.
-
Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.J Pharmacol Exp Ther. 1982 Jul;222(1):14-9. J Pharmacol Exp Ther. 1982. PMID: 7086695
-
Retrograde perfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats.J Pharmacol Exp Ther. 1981 Feb;216(2):339-46. J Pharmacol Exp Ther. 1981. PMID: 7463352
-
A new model-independent physiological approach to study hepatic drug clearance and its applications.Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6389376 Review.
-
Altered hepatic blood flow and drug disposition.Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005. Clin Pharmacokinet. 1976. PMID: 13954 Review.
Cited by
-
Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.J Pharmacokinet Biopharm. 1992 Feb;20(1):19-61. doi: 10.1007/BF01143185. J Pharmacokinet Biopharm. 1992. PMID: 1588503
-
Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method.Proc Natl Acad Sci U S A. 1988 Nov;85(21):8355-9. doi: 10.1073/pnas.85.21.8355. Proc Natl Acad Sci U S A. 1988. PMID: 2903504 Free PMC article.
-
The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.Toxics. 2023 Oct 21;11(10):874. doi: 10.3390/toxics11100874. Toxics. 2023. PMID: 37888724 Free PMC article. Review.
-
A physiologically-based flow network model for hepatic drug elimination I: regular lattice lobule model.Theor Biol Med Model. 2013 Sep 5;10:52. doi: 10.1186/1742-4682-10-52. Theor Biol Med Model. 2013. PMID: 24007328 Free PMC article.
-
Drug structure-transport relationships.J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):541-73. doi: 10.1007/s10928-010-9174-0. Epub 2010 Nov 24. J Pharmacokinet Pharmacodyn. 2010. PMID: 21107662 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical